Gilead Antiviral Drug Shows the Most Potential for COVID-19, Say

来源: 2020-02-25 02:43:49 [] [博客] [旧帖] [给我悄悄话] 本文已被阅读: 次 (4168 bytes)
本文内容已被 [ 方家胡同 ] 在 2020-02-25 02:46:16 编辑过。如有问题,请报告版主或论坛管理删除.

says WHO official


Gilead Sciences (NASDAQ:GILD) received a vote of confidence from the World Health Organization on Monday when a WHO official said that its experimental COVID-1) drug shows great potential.

Bruce Aylward, assistant director-general of the World Health Organization, went on to say during a Beijing briefing that remdesivir seems to be the "one drug right now that we think may have efficacy." Shares of Gilead shot up by as much as 6.9% following the briefing.

Remdesivir was originally developed to be an Ebola vaccine, but it proved less effective than was hoped against that disease. However, back in January, one COVID-19 patient who received remdesivir on a compassionate use basis saw a substantial improvement in symptoms. Since then, the Chinese government has started human trials with remdesivir, with WHO stating that clinical results would be available within weeks.



  • 笔名:      密码: 保持登录状态一个月,直到我退出登录。
  • 标题:
  • 内容(可选项): [所见即所得|预览模式] [HTML源代码] [如何上传图片] [怎样发视频] [如何贴音乐]